UPDATE: Staar Surgical jumps on FDA panel nod

An FDA panel votes to recommend approval of Staar Surgical's Visian Toric implantable collamer lens for treating myopic astigmatism, sending shares up today on Wall Street. An FDA advisory panel voted last week to recommend approval for Staar Surgical's (NSDQ:STAA) Visian Toric implantable collamer lens for myopic astigmatism, sending STAA shares up nearly 17% today. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Optical/Ophthalmic, Regulatory/Complianceread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news